S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/BVF Partners/Q1 2021

BVF Partners

Periodo: Q1 2021 Β· Depositato: 2021-05-17
Vedi su SEC EDGAR β†—
AUM
$2.67B
Valore totale del portafoglio
Posizioni
67
Titoli dichiarati
Prima Posizione
FPRX
8.9% $238.8M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-05-17) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
FPRXFIVE PRIME THERAPEUTICS INC$238.8M8.95%β€”β€”
8.9%
OLMAOLEMA PHARMACEUTICALS INC$221.0M8.29%$33.18$12.64-61.9%
8.3%
MRUSMERUS N V$152.2M5.71%β€”β€”
5.7%
XOMAXOMA CORP DEL$144.1M5.40%$40.81$43.00+5.4%
5.4%
RVMDREVOLUTION MEDICINES INC$135.0M5.06%$45.88$189.24+312.5%
5.1%
RPTXREPARE THERAPEUTICS INC$114.2M4.28%β€”β€”
4.3%
PTGXPROTAGONIST THERAPEUTICS INC$102.5M3.84%$25.90$131.62+408.2%
3.8%
KYMRKYMERA THERAPEUTICS INC$102.2M3.83%$38.86$113.51+192.1%
3.8%
RLAYRELAY THERAPEUTICS INC$99.3M3.72%$34.57$18.65-46.0%
3.7%
ARGXARGENX SE$85.3M3.20%$275.39$939.68+241.2%
3.2%
EPIXESSA PHARMA INC$84.5M3.17%β€”β€”
3.2%
XENEXENON PHARMACEUTICALS INC$62.3M2.34%$17.90$60.96+240.6%
2.3%
IONSIONIS PHARMACEUTICALS INC$61.4M2.30%$44.96$81.80+81.9%
2.3%
IDYAIDEAYA BIOSCIENCES INC$61.3M2.30%$23.50$37.65+60.2%
2.3%
ACIUAC IMMUNE SA$57.1M2.14%$7.61$2.51-67.0%
2.1%
RCUSARCUS BIOSCIENCES INC$52.7M1.98%$28.08$30.33+8.0%
2.0%
LXRXLEXICON PHARMACEUTICALS INC$49.3M1.85%$5.87$2.32-60.5%
1.9%
KURAKURA ONCOLOGY INC$46.2M1.73%$28.27$11.10-60.7%
1.7%
IKNAIKENA ONCOLOGY INC$45.2M1.69%β€”β€”
1.7%
FDMT4D MOLECULAR THERAPEUTICS IN$44.7M1.68%$43.38$13.00-70.0%
1.7%
CGEMCULLINAN ONCOLOGY INC$43.7M1.64%$41.67$17.63-57.7%
1.6%
CTMXCYTOMX THERAPEUTICS INC$43.1M1.62%$7.73$3.82-50.6%
1.6%
MTEMXXXXMOLECULAR TEMPLATES INC$36.1M1.36%β€”β€”
1.4%
SPROSPERO THERAPEUTICS INC$31.5M1.18%$14.72$2.20-85.0%
1.2%
GLYCGLYCOMIMETICS INC$28.7M1.08%β€”β€”
1.1%
VIRXVIRACTA THERAPEUTICS INC$28.6M1.07%β€”β€”
1.1%
VSTMXXXXVERASTEM INC$28.4M1.06%β€”β€”
1.1%
INFIQINFINITY PHARMACEUTICALS INC$27.1M1.02%$3.23$0.00
1.0%
OVIDOVID THERAPEUTICS INC$25.8M0.97%$4.02$2.69-33.1%
1.0%
ANABANAPTYSBIO INC$25.6M0.96%$14.37$63.42+341.3%
1.0%

AttivitΓ  Trimestre su Trimestre

Q1 2021 vs. Q4 2020

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
IKNAIKENA ONCOLOGY INC$45.2M
CGEMCULLINAN ONCOLOGY INC$43.7M-57.7%
VIRXVIRACTA THERAPEUTICS INC$28.6M
ANABANAPTYSBIO INC$25.6M+341.3%
SLNSILENCE THERAPEUTICS PLC$15.8M
ANGNANGION BIOMEDICA CORP$15.8M
REPLREPLIMUNE GROUP INC$14.1M
ELDNELEDON PHARMACEUTICALS INC$11.9M

Posizioni Chiuse (8)

TickerEmittenteNozionale
CYTKCYTOKINETICS INC$101.4M
XNCRXENCOR INC$55.2M
ALXOALX ONCOLOGY HLDGS INC$46.6M
NVUSNOVUS THERAPEUTICS INC$11.8M
GMDAQGAMIDA CELL LTD$11.3M
CRISCURIS INC$5.1M
PHATPHATHOM PHARMACEUTICALS INC$5.0M
RGLSREGULUS THERAPEUTICS INC$4.6M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
FPRXFIVE PRIME THERAPEUTICS INC$221.1M+510.3%
ARGXARGENX SE$66.9M+395.4%+241.2%
CFRXCONTRAFECT CORP$10.2M+138.3%
IMVTIMMUNOVANT INC$-5.4M+122.4%
CRVSCORVUS PHARMACEUTICALS INC$3.0M+66.1%
OVIDOVID THERAPEUTICS INC$15.3M+41.9%-33.1%
XFORXXXXX4 PHARMACEUTICALS INC$4.3M+37.7%
MTEMXXXXMOLECULAR TEMPLATES INC$16.0M+33.3%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
AMRNXXXXAMARIN CORP PLC$-42.0M-84.1%
SNDXSYNDAX PHARMACEUTICALS INC$-15.9M-81.4%
STROSUTRO BIOPHARMA INC$-21.4M-55.4%
INFIQINFINITY PHARMACEUTICALS INC$-9.9M-51.9%
RCUSARCUS BIOSCIENCES INC$-18.8M-31.8%+8.0%
GRTSQGRITSTONE ONCOLOGY INC$6.9M-30.9%
RNACSELECTA BIOSCIENCES INC$0.8M-28.0%
ACIUAC IMMUNE SA$6.4M-23.6%-67.0%
← Torna agli Hedge Fund